{
    "2019-12-17": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Stock Sinks",
                        "Market Gains"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-12-15",
                "original_text": "Colorado life science companies brought in more than $12 billion in 2019",
                "features": {
                    "keywords": [
                        "Colorado",
                        "life science",
                        "$12 billion"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-07-14",
                "original_text": "S&P 500, Dow and Nasdaq score fresh records at close",
                "features": {
                    "keywords": [
                        "S&P 500",
                        "Dow",
                        "Nasdaq",
                        "fresh records"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-10",
                "original_text": "Morphic Holding Tabbed as Likely to Develop Blockbuster Drug",
                "features": {
                    "keywords": [
                        "Morphic Holding",
                        "Blockbuster Drug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2022-05-18",
                "original_text": "Pfizer wins FDA approval for 'first and only' oral treatment for prostate cancer drug",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "FDA approval",
                        "prostate cancer drug"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-01-28",
                "original_text": "Pfizer Invites Public to View and Listen to Webcast of January 28 Conference Call with Analysts",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Webcast",
                        "Conference Call"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2022-08-12",
                "original_text": "Pfizer's Xtandi Gets FDA Nod for Expanded Patient Group",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Xtandi",
                        "FDA Nod",
                        "Expanded Patient Group"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-20",
                "original_text": "The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",
                "features": {
                    "keywords": [
                        "Roche",
                        "US Antitrust Clearance",
                        "Spark Purchase",
                        "Orphan Drug",
                        "Dynavax",
                        "CEO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-05",
                "original_text": "Markets Extend Rally, Led by Tech Sector",
                "features": {
                    "keywords": [
                        "Markets",
                        "Rally",
                        "Tech Sector"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}